Tomoshige Fujino

Tomoshige Fujino

Auto-generated profile, based on publicly available information

Tomoshige Fujino

Department of Biomolecular Engineering, Graduate School of Engineering, Nagoya University, Nagoya, Japan

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2024 in The EMBO Journal
Verified
Journal Article
Open access
KYKoji Yamano
Koji Yamano
MSMomoha Sawada
Momoha Sawada
RKReika Kikuchi
Reika Kikuchi
KNKafu Nagataki
Kafu Nagataki
WKWaka Kojima
Waka Kojima
NMNoriyuki Matsuda
Noriyuki Matsuda
Tank-binding kinase 1 (TBK1) is a Ser/Thr kinase that is involved in many intracellular processes, such as innate immunity, cell cycle, and apoptosis. TBK1 is also important for phosphorylating the autophagy adaptors that mediate the selective autophagic removal of damaged mitochondria. However, the mechanism by which PINK1-Parkin-mediated mitophagy activates TBK1 remains largely unknown. Here, we show that the autophagy adaptor optineurin (OPTN) provides a unique platform for TBK1 activation. Both the OPTN-ubiquitin and the OPTN-pre-autophagosomal structure (PAS) interaction axes facilitate assembly of the OPTN-TBK1 complex at a contact sites between damaged mitochondria and the autophagosome formation sites. At this assembly point, a positive feedback loop for TBK1 activation is initiated that accelerates hetero-autophosphorylation of the protein. Expression of monobodies engineered here to bind OPTN impaired OPTN accumulation at contact sites, as well as the subsequent activation of TBK1, thereby inhibiting mitochondrial degradation. Taken together, these data show that a positive and reciprocal relationship between OPTN and TBK1 initiates autophagosome biogenesis on damaged mitochondria.

16 October 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
TKT. Kondo
T. Kondo
YIY. Iwatani
Y. Iwatani
KMK. Matsuoka
K. Matsuoka
TFT. Fujino
T. Fujino
SUS. Umemoto
S. Umemoto
HMHiroshi Murakami
Hiroshi Murakami
To combat SARS-CoV-2 and any unknown emerging pathogens in the future, the development of a rapid and effective method to generate high-affinity antibodies or antibody-like proteins is of critical importance. We here report a high-speed in vitro selection of multiple high-affinity antibody-like proteins against various targets including the SARS-CoV-2 spike protein. The sequences of monobodies against the SARS-CoV-2 spike protein were successfully procured within only four days. Furthermore, the obtained monobody efficiently captured SARS-CoV-2 particles from the nasal swab samples of patients and exhibited a high neutralizing activity against SARS-CoV-2 infection (IC50 = 0.5 nM). The high-speed in vitro selection of antibody-like proteins would be useful for the rapid development of a detection method and a neutralizing protein against a virus responsible for an ongoing, and possibly a future, pandemic.

2 February 2021 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
TKTaishi Kondo
Taishi Kondo
MEMinori Eguchi
Minori Eguchi
SKSeita Kito
Seita Kito
TFTomoshige Fujino
Tomoshige Fujino
GHGosuke Hayashi
Gosuke Hayashi
HMHiroshi Murakami
Hiroshi Murakami
Rapid in vitro selection of antibody-like proteins using a stable version of the transcription–translation coupled with association of puromycin linker (TRAP) display.

16 May 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
TFTomoshige Fujino
Tomoshige Fujino
RSRyogo Sonoda
Ryogo Sonoda
THTaito Higashinagata
Taito Higashinagata
EMEmi Mishiro-Sato
Emi Mishiro-Sato
KKKeiko Kano
Keiko Kano
HMHiroshi Murakami
Hiroshi Murakami
The Ser/Leu-swapped genetic code can act as a genetic firewall, mitigating biohazard risks arising from horizontal gene transfer in genetically modified organisms. Our prior work demonstrated the orthogonality of this swapped code to the standard genetic code using a cell-free translation system comprised of 21 in vitro transcribed tRNAs. In this study, to advance this system for protein engineering, we introduce a natural/in vitro transcribed-hybrid tRNA set. This set combines natural tRNAs from Escherichia coli (excluding Ser, Leu, and Tyr) and in vitro transcribed tRNAs, encompassing anticodon-swapped tRNASerGAG and tRNALeuGGA. This approach reduces the number of in vitro transcribed tRNAs required from 21 to only 4. In this optimized system, the production of a model protein, superfolder green fluorescent protein, increases to 3.5-fold. With this hybrid tRNA set, the Ser/Leu-swapped cell-free translation system will stand as a potent tool for protein production with reduced biohazard concerns in future biological endeavors.

23 April 2026 in Nature Chemistry
Verified
Journal Article
Closed access
PDF file
TMTomoki Miyazaki
Tomoki Miyazaki
TFTomoshige Fujino
Tomoshige Fujino
TYTatsuyuki Yoshii
Tatsuyuki Yoshii
HKHaruto Kosugi
Haruto Kosugi
MFMamoru Funane
Mamoru Funane
STShinya Tsukiji
Shinya Tsukiji

19 May 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
SUS. Umemoto
S. Umemoto
TKT. Kondo
T. Kondo
TFT. Fujino
T. Fujino
GHGosuke Hayashi
Gosuke Hayashi
HMHiroshi Murakami
Hiroshi Murakami
Messenger ribonucleic acid (mRNA) sequences influence the translation efficiency and accuracy. To increase our knowledge of how mRNA sequences affect ribosome translation and apply the obtained information to improve the mRNA display method, we conducted a comprehensive analysis of the effect of mRNA sequences on the translation. Translation efficiency depended strongly on the three codons following the start codon. Furthermore, the codons at the ribosomal E- and P-sites strongly influence the misreading of the A-site blank codon by near-cognate transfer RNA. The purine base after the blank codon also induced a higher misread rate than that with a pyrimidine base. Based on these findings, we demonstrated construction of highly diverse monobody and macrocyclic peptide libraries that would be useful in developing functional peptides and proteins in the future.